Men drive rush for new HIV prevention injection

By: Staff Reporter

KAMPALA — Health facilities across Uganda are reporting growing interest in a new HIV prevention injection that requires administration only twice a year, with men emerging as one of the largest groups seeking access to the groundbreaking treatment.

The injection, known as lenacapavir, has been hailed by health experts as a major advancement in HIV prevention due to its high effectiveness and convenience. Unlike traditional daily oral pre-exposure prophylaxis (PrEP) pills, the injection is administered once every six months, making it easier for users to maintain protection against HIV infection.

Medical workers say many men who were previously reluctant to use daily preventive medication are now embracing the injectable option because it is discreet and eliminates the burden of remembering to take a pill every day.

"We are seeing increasing numbers of men coming forward to inquire about the injection," said a healthcare provider at a Kampala-based HIV prevention clinic. "Many say the six-month protection period makes it much easier to stay protected."

The surge in demand has, however, created concerns about supply shortages. Some health facilities have reported limited stock levels as awareness of the new prevention method continues to spread through communities and social media.

Public health advocates believe the injectable PrEP could play a critical role in reducing new HIV infections, particularly among populations at higher risk of exposure. They note that adherence to daily pills has long been one of the biggest challenges in HIV prevention efforts.

According to health experts, the injection has demonstrated exceptionally high effectiveness in clinical trials, offering protection levels comparable to the best available HIV prevention methods.

Uganda continues to make progress in its fight against HIV/AIDS, but thousands of new infections are still recorded each year. Health officials say innovative prevention tools such as lenacapavir could help accelerate efforts to achieve national and global HIV reduction targets.

Despite the optimism, experts caution that the injection is not a substitute for comprehensive HIV prevention strategies. Regular testing, safe sexual practices, access to condoms, and public awareness campaigns remain essential components of the country's response to the epidemic.

As health authorities work to secure additional supplies, many Ugandans are hopeful that wider access to the twice-yearly injection will offer a new and powerful weapon in the fight against HIV.